[(WR)(8)WKβA]-Doxorubicin Conjugate: A Delivery System to Overcome Multi-Drug Resistance against Doxorubicin

Doxorubicin (Dox) is an anthracycline chemotherapeutic agent used to treat breast, leukemia, and lymphoma malignancies. However, cardiotoxicity and inherent acquired resistance are major drawbacks, limiting its clinical application. We have previously shown that cyclic peptide [WR](9) containing alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoghebi, Khalid, Aliabadi, Hamidreza Montazeri, Tiwari, Rakesh Kumar, Parang, Keykavous
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774489/
https://www.ncbi.nlm.nih.gov/pubmed/35053417
http://dx.doi.org/10.3390/cells11020301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774489/
https://www.ncbi.nlm.nih.gov/pubmed/35053417
http://dx.doi.org/10.3390/cells11020301

Ejemplares similares